Assessing Pharmacists' Understanding and Practice of Urine Drug Screening for Diabetic Neuropathy Patients treated in a pain clinic a cross sectional study in Punjab, Pak

Assessing Pharmacists' Understanding and Practice of Urine Drug Screening for Diabetic Neuropathy Patients treated in a pain clinic a cross sectional study in Punjab, Pak - UDSDN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052899

Enrollment

Registered

2023-11-25

Start date

2023-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pharmacists working in pain clinic

Exclusion criteria

Exclusion criteria: Trainees, pharmacy students and visiting pharmacists

Design outcomes

Primary

Measure	Time frame
To Evaluate the Level of Knowledge: Assess the depth of understanding among pharmacists regarding urine drug screening practices for diabetic neuropathy patients undergoing treatment at pain clinics in Punjab, Pakistan. To Assess Implementation and Compliance: Determine the extent to which pharmacists apply urine drug screening protocols in their practice for diabetic neuropathy patients within pain clinic settings in Punjab, Pakistan, and ascertain their adherence to recommended guidelines.	—

Measure

Time frame

To Evaluate the Level of Knowledge: Assess the depth of understanding among pharmacists regarding urine drug screening practices for diabetic neuropathy patients undergoing treatment at pain clinics in Punjab, Pakistan. To Assess Implementation and Compliance: Determine the extent to which pharmacists apply urine drug screening protocols in their practice for diabetic neuropathy patients within pain clinic settings in Punjab, Pakistan, and ascertain their adherence to recommended guidelines.

—

Secondary

Measure	Time frame
Pharmacists' Confidence Levels: Assess the confidence levels of pharmacists in interpreting and acting upon urine drug screening results for diabetic neuropathy patients in pain clinic settings. Patient Satisfaction and Understanding: Evaluate the level of satisfaction and understanding among diabetic neuropathy patients regarding the purpose and implications of urine drug screening conducted by pharmacists within pain clinic care.	—

Measure

Time frame

Pharmacists' Confidence Levels: Assess the confidence levels of pharmacists in interpreting and acting upon urine drug screening results for diabetic neuropathy patients in pain clinic settings. Patient Satisfaction and Understanding: Evaluate the level of satisfaction and understanding among diabetic neuropathy patients regarding the purpose and implications of urine drug screening conducted by pharmacists within pain clinic care.

—

Countries

Asia(except Japan)

Contacts

Public ContactSaima Abbass

Shifa Hospital Sheikhupura

saimaabasstahammal@gmail.com923245065017

Outcome results